Skip to main content

CORRECTION article

Front. Pharmacol., 31 July 2023
Sec. Experimental Pharmacology and Drug Discovery
Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1264737

Expression of Concern: A new method for ethical and efficient evidence generation for off-label medication use in oncology (a case study in glioblastoma)

This article is a correction to:

  1. A New Method for Ethical and Efficient Evidence Generation for Off-Label Medication Use in Oncology (A Case Study in Glioblastoma)

    1. Read original article
Frontiers Editorial Office Frontiers Editorial Office*

An Expression of concern on:
A new method for ethical and efficient evidence generation for off-label medication use in oncology (a case study in glioblastoma)

by Agrawal S, Vamadevan P, Mazibuko N, Bannister R, Swery R, Wilson S and Edwards S (2019). Front. Pharmacol. 10:681. doi: 10.3389/fphar.2019.00681

With this notice, Frontiers states its awareness of concerns regarding the METRICS study described in this article. This expression of concern has been posted while Frontiers investigates the allegations. The situation will be updated as soon as the investigation is complete.

Citation: Frontiers Editorial Office (2023) Expression of Concern: A new method for ethical and efficient evidence generation for off-label medication use in oncology (a case study in glioblastoma). Front. Pharmacol. 14:1264737. doi: 10.3389/fphar.2023.1264737

Received: 21 July 2023; Accepted: 21 July 2023;
Published: 31 July 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.